Corporate Profile 2014

www.bharatbiotech.com

Fast Facts

Issues

Products

Executive Summary
R&D Pipeline

Projects

Recognition
www.bharatbiotech.com

Fast Facts

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Recognition

Vision

Established

: 1996

Promoters

: Dr. Krishna & Ms. Suchitra Ella

Business Line

: Vaccines and Bio-therapeutics

First Project

: Hepatitis B Vaccine - US $ 3.5 Mn

Investment

: Over US $ 150 Mn till date

Facility

: One of the largest facilities in Asia

Personnel

: 700 resources including scientists

Accreditations : Korean FDA, ANVISA, other Countries

Innovation

Projects

: 50 Global patents

To offer affordable, safe

and effective healthcare
solutions to combat mankind's
most dreaded illnesses, and to
thus eradicate or at least control
their occurrence in the years to
come.

Mission
Developing next-generation
remedies through Genetic
Engineering Technologies so as to
create a healthier world.

Mission 7 Billion
www.bharatbiotech.com

Issues

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

TYPHOID

HEPATITIS

ROTA

SCHISTOSOMIASIS

E. COLI

CHOLERA

OTHER DIARRHEA

JE

DENGUE

CHIKUNGUNYA

MALARIA

TRYPANOSOMA

LEISHMANIA

FILARIA

NEGLECTED APPROACH

NEGLECTED DISEASES

Emerging Country Challenges

POLITICAL
COMMITTMENT

SCIENTIFIC
COMMITTMENT

Lack of clarity on disease burden, public health focus & policies

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

Thinking Future
NEGLECTED DISEASES
1

DENGUE

GLOBAL DISEASES

CHIKUNGUNYA

PLAGUE

TRYPANOSOMA

HIV

LEISHMANIA

INFLUENZA

FILARIA

MALARIA

JAPANESE ENCEPHALITIS

No DW manufactures develop new vaccines.

Most DW manufactures are biogeneric players.
DC manufactures follow MNCs.
Our Mission is to change that mindset.

Todays neglected diseases - Tomorrows global diseases

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

Emerging Market Value Proposition

Our growth path for
future is here

Developed

Emerging

Population

0.75 Billion

6 Billion

Birth Cohort

7.5 Million

125 Million

High Value

Low Value

Low Volume

High Volume

Health Care Budgets

Decreasing

Health Care Budgets

Increasing

Bharat Biotech Strategy

www.bharatbiotech.com

Products

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

JE Launch
1st indigenously developed

Purified, Inactivated Japanese Encephalitis Vaccine

The Union Health & Family Welfare Minister, Shri Ghulam Nabi Azad launching
Japanese Encephalitis vaccine on 04th October, 2013 in New Delhi

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

TCV Launch
Worlds 1st Clinically Proven Typhoid Conjugate Vaccine

Vi Capsular Polysaccharide Tetanus Toxoid Conjugate Vaccine

Dr. Christian Loucq - International Vaccine Institute Director-General launching

Typhoid Conjugate Vaccine in Hyderabad on 26th August, 2013

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

Product Launches

Dr. A.P.J. Abdul Kalam

Former President of India, launching

Dr. John Robbins

Dr. Julie Gerberding

Father of Polysaccharide Vaccine

National Institute of Health, USA, launching

Former Director of the U.S. Centers for

Disease Control, launching

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

Vaccines
Children
S. No. Vaccine

Children & Adult

Brand

S. No. Vaccine

Brand

DPT+ Hep B + Hib

Comvac 5

Typhoid

Typbar

DPT+ Hep B

Comvac 4-Hb

Typhoid

Typbar TCV

DPT; TT, DT

Comvac 3

Rabies

INDIRAB

Hep B

Revac B+

Influenza

HN VAC

Hep B

Revac B mcf

JE

Jenvac

Hib

BioHib

Typhoid

Typbar

Typhoid

Typbar TCV

OPV Trivalent

BIOPOLIO

10

OPV Monovalent Type-1

BIOPOLIO M1

Typhoid

Typbar

11

OPV Monovalent Type-3

BIOPOLIO M3

Typhoid

Typbar TCV

12

OPV Bivalent

BIOPOLIO B1/3

Influenza

HN VAC

13

JE

Jenvac

JE

Jenvac

Traveler
S. No. Vaccine

Brand

Wide Product Portfolio

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

Bio-therapeutics
S. No. Bio-therapeutic

Brand

Probiotic Yeast

BIOGIT

Recombinant Human Epidermal

Growth Factor

REGEN-D

Recombinant Human Epidermal

Growth Factor, Silver Sulfadiazine &
Chlorexidine Gluconate Cream

SLVRGEN

Zinc with ORS

ZELECT

Wide Product Portfolio

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

Product Distribution

More than 2 Billion doses delivered

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

Accreditation
Belarus
Turkey

Ukraine
Kazakhstan
Syria
Pakistan

Colombia
(INVIMA)

Ivory Coast
Ghana
Congo
Brazil
(ANVISA)

Saudi
Arabia
Uganda
Kenya

Korea
Nepal
Myanmar
Philippines

Sri Lanka

Malawi

More than 2 Billion doses delivered

www.bharatbiotech.com

R&D Pipeline

www.bharatbiotech.com

Fast Facts

Issues

Pipeline Products
S. No.

Vaccines

Products

Product
Development

Preclinical
Testing

R&D Pipeline

Phase I

Projects

Phase II

Recognition

Phase III

Commercial
License

Chikungunya

2017

Malaria PvRII

2017

Staph Aureus MRSA

2018

Human Papilloma Virus

2018

Acellular Pertussis

2016

Tetanus (Meat Free)

2016

S. Paratyphi

2018

NTS Conjugates

2018

Sabin IPV

2018
Product
Development

Therapeutics

Preclinical
Testing

Phase I

Phase II

Phase III

Commercial
License

THR-100

2015

Lysostaphin Topical

2015

Lysostaphin IV

2017

r Human Serum Albumin

2014

1st Time in the world Typhoid Conjugate Vaccine

www.bharatbiotech.com

Projects

www.bharatbiotech.com

Recognition

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

Recognition of Achievements

VOA awards 2013

most promising vaccines for paediatric
16th March, 2013

Best R&D Company of the year 2010

by Pharmaceutical Leadership Summit
2010 Mumbai

Pharma Bio World Award

Business Leader of the Year
Biotechnology 2011

Business Innovation Marico Foundation

& Business World 2006

National Technology
Award Govt of India 2006

Young Enterprising Company

www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

Recognition of Achievements

JRD TATA Best Entrepreneur award

TDB National award

FICCI Award Excellence in Science

Best Performance in Technology

Marico Foundation Innovation Award

DBT-award for Product & Process

Young Enterprising Company

www.bharatbiotech.com

Mission 7 Billion
Our mission is to address the health care needs of emerging markets,
drive innovation, be a front runner in research and development of
new vaccines and bio-therapeutics

Dr. Krishna M. Ella

Chairman & Managing Director
www.bharatbiotech.com

Fast Facts

Issues

Products

R&D Pipeline

Projects

Recognition

Address
Bharat Biotech International Limited
Genome Valley, Shameerpet Mandal,
Ranga Reddy District - 500 078 Andhra Pradesh, India.
Tel.: +91 40 2348 0567
Fax: +91 40 2348 0560
info@bharatbiotech.com
www.bharatbiotech.com

Thank You
www.bharatbiotech.com